Short Interest in Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Drops By 43.4%

Advanced Medical Isotope Corporation (OTCMKTS:RDGL) saw a significant drop in short interest in the month of December. As of December 15th, there was short interest totaling 62,811 shares, a drop of 43.4% from the November 30th total of 110,911 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 816,554 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily trading volume, of 816,554 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.0% of the company’s shares are sold short.

Advanced Medical Isotope Price Performance

Advanced Medical Isotope stock opened at $0.07 on Monday. The company’s 50 day simple moving average is $0.07 and its 200-day simple moving average is $0.10. Advanced Medical Isotope has a 1 year low of $0.04 and a 1 year high of $0.17.

Advanced Medical Isotope Company Profile

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc in December 2017. Vivos Inc was incorporated in 1994 and is headquartered in Richland, Washington.